Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
Key Laboratory of Cancer Genomic Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
Signal Transduct Target Ther. 2024 Jun 19;9(1):149. doi: 10.1038/s41392-024-01848-7.
Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite pervasive somatic mutations and clonal expansion in normal tissues, their transformation into cancer remains a rare event, indicating the presence of additional driver events for progression to an irreversible, highly heterogeneous, and invasive lesion. Recently, researchers are emphasizing the mechanisms of environmental tumor risk factors and epigenetic alterations that are profoundly influencing early clonal expansion and malignant evolution, independently of inducing mutations. Additionally, clonal evolution in tumorigenesis reflects a multifaceted interplay between cell-intrinsic identities and various cell-extrinsic factors that exert selective pressures to either restrain uncontrolled proliferation or allow specific clones to progress into tumors. However, the mechanisms by which driver events induce both intrinsic cellular competency and remodel environmental stress to facilitate malignant transformation are not fully understood. In this review, we summarize the genetic, epigenetic, and external driver events, and their effects on the co-evolution of the transformed cells and their ecosystem during tumor initiation and early malignant evolution. A deeper understanding of the earliest molecular events holds promise for translational applications, predicting individuals at high-risk of tumor and developing strategies to intercept malignant transformation.
肿瘤发生是一个多步骤的过程,正常细胞中的致癌突变赋予克隆优势作为初始事件。然而,尽管正常组织中存在广泛的体细胞突变和克隆扩增,但它们转化为癌症仍然是一个罕见的事件,这表明存在其他驱动事件促进进展为不可逆转的、高度异质性和侵袭性病变。最近,研究人员强调了环境肿瘤风险因素和表观遗传改变的机制,这些机制深刻地影响了早期克隆扩增和恶性演变,而不诱导突变。此外,肿瘤发生中的克隆进化反映了细胞内在特征和各种细胞外在因素之间的多方面相互作用,这些因素施加选择性压力,要么抑制不受控制的增殖,要么允许特定克隆进展为肿瘤。然而,驱动事件如何诱导内在细胞能力和重塑环境压力以促进恶性转化的机制尚不完全清楚。在这篇综述中,我们总结了遗传、表观遗传和外部驱动事件,以及它们对肿瘤起始和早期恶性演变过程中转化细胞及其生态系统共同进化的影响。更深入地了解最早的分子事件有望为转化应用提供帮助,预测高风险肿瘤的个体,并制定策略来拦截恶性转化。